Mercapturate metabolism of 4-hydroxy-2-nonenal in rat and human cerebrum

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 2, 2003, Pages 146-153

  Sidell, Kathrin R ^a   Montine, Kathleen S ^c   Picklo Sr , Matthew J ^a   Olsen, Sandra J ^a   Amarnath, Ventkataraman ^e   Montine, Thomas J ^a,b,d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e NONE

Author keywords

4 hydroxy 2 nonenal (HNE); Alzheimer disease; Glutathione transferases; Lipid peroxidation; Mercapturic acid pathway

Indexed keywords

4 HYDROXYNONENAL; ACETYLCYSTEINE; AMYLOID BETA PROTEIN; GLUTATHIONE TRANSFERASE; POLYUNSATURATED FATTY ACID;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN METABOLISM; CONTROLLED STUDY; DETOXIFICATION; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; NEUROTOXICITY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; SYNAPTOSOME;

EID: 0037317983     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.2.146     Document Type: Article

References (36)

1. Keller JN, Pang Z, Geddes JW, Begley JG, Germeyer A, Waeg G, Mattson MP. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: Role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 1997;69:273-84
2. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem 1997;68:255-64
3. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP. Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation. J Neurosci 1997;17:1046-54
4. Montine KS, Kim PJ, Olson SJ, Markesbery WR, Montine TJ. 4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J Neuropathol Exp Neurol 1997;56:866-71
5. Montine KS, Reich E, Neely MD, et al. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. J Neuropathol Exp Neurol 1998;57:415-25
6. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA. 4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997;68:2092-97
7. Lovell MA, Ehmann WD, Mattson MP, Markesbery WR. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol Aging 1997;18:457-61
8. Algar EM, Holmes RS. Purification and properties of mouse stomach aldehyde dehydrogenase. Evidence for a role in the oxidation of peroxidic and aromatic aldehydes. Biochim Biophys Acta 1989;995:168-73
9. Mitchell DY, Petersen DR. Oxidation of aldehydic products of lipid peroxidation by rat liver microsomal aldehyde dehydrogenase. Arch Biochem Biophys 1989;269:11-17
10. Picklo MJ, Olson SJ, Markesbery WR, Montine TJ. Expression and activities of aldo-keto oxidoreductases in Alzheimer disease. J Neuropathol Exp Neurol 2001;60:686-95
11. Xie C, Lovell M, Markesbery WR. Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity. Free Radic Biol Med 1998;25:979-88
12. Neely MD, Amarnath V, Weitlauf C, Montine TJ. Synthesis and cellular effects of an intracellularly activated analogue of 4-hydroxynonenal. Chem Res Toxicol 2002;15:40-47
13. Gioacchini AM, Calonghi N, Boga C, et al. Determination of 4-hydroxy-2-nonenal at cellular levels by means of electrospray mass spectrometry. Rapid Commun Mass Spectrom 1999;13:1573-79
14. Alary J, Debrauwer L, Fernanadez Y, et al. Identification of novel urinary metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in rats. Chem Res Toxicol 1998;11:1368-76
15. Hartley DP, Ruth JA, Petersen DR. The hepatocellular metabolism of 4-hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase, and glutathione S-transferase. Arch Biochem Biophys 1995;316:197-205
16. The Ronald and Nancy Reagan Institute of the Alzheimer's Association and National Institute on Aging Working Group. Consensus Report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". Neurobiol Aging 1998;19:109-16
17. Janowsky A, Neve K, Eshleman A. Uptake and release of neurotransmitters. In: Crawley J, Gerfen C, McKay R, Rogawski M, Sibley D, Skolnick P, eds. Current protocols in neuroscience. New York: John Wiley and Sons, 1998
18. Sidell KR, Olson SJ, Ou JJ, Zhang Y, Amarnath V, Montine TJ. Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivo. J Neurochem 2001;79:510-21
19. Canuto RA, Muzio G, Bassi AM, et al. Metabolism of 4-hydroxynonenal in hepatoma cell lines. Adv Exp Med Biol 1991;284:75-84
20. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128
21. Philbert MA, Beiswanger CM, Manson MM, et al. Glutathione S-transferases and gamma-glutamyl transpeptidase in the rat nervous system: A basis for differential susceptibility to neurotoxicants. Neurotoxicology 1995;16:349-62
22. Tansey FA, Cammer W. A pi form of glutathione-S-transferase is a myelin- and oligodendrocyte-associated enzyme in mouse brain. J Neurochem 1991;57:95-102
23. Laurent A, Perdu-Durand E, Alary J, Debrauwer L, Cravedi JP. Metabolism of 4-hydroxynonenal, a cytotoxic product of lipid peroxidation, in rat precision-cut liver slices. Toxicol Lett 2000;114:203-14
24. Campbell JA, Corrigall AV, Guy A, Kirsch RE. Immunohistologic localization of alpha, mu, and pi class glutathione-S-transferases in human tissues. Cancer 1991;67:1608-13
25. Carder PJ, Hume R, Fryer AA, Strange RC, Lauder J, Bell JE. Glutathione S-transferase in human brain. Neuropathol Appl Neurobiol 1990;16:293-303
26. Aksenov MY, Markesbery WR. Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease. Neurosci Lett 2001;302:141-45
27. Singhal SS, Zimniak P, Awasthi S, et al. Several closely related glutathione-S-transferase isozymes catalyzing conjugation of 4-hydroxynonenal are differentially expressed in human tissues. Arch Biochem Biophys 1994;311:242-50
28. Singhal SS, Zimniak P, Sharma R, Srivastava SK, Awasthi S, Awasthi YC. A novel glutathione S-transferase isozyme similar to GST 8-8 of rat and mGSTA4-4 (GST 5.7) of mouse is selectively expressed in human tissues. Biochim Biophys Acta 1994;1204:279-86
29. Eaton DL, Bammler TK. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 1999;49:156-64
30. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600
31. Hiratsuka A, Tobita K, Saito H, et al. Preferential detoxification of 4-hydroxy-2-nonenal enantiomers by hepatic glutathione S-tranferase isoforms in guinea pigs and rats. Biochem J 2001;355:237-44
32. Hubatsch I, Ridderstrom M, Mannervik B. Human glutathione transferase A4-4: An alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation. Biochem J 1998;330:175-79
33. Hussey AJ, Hayes JD. Human Mu-class glutathione S-transferases present in liver, skeletal muscle and testicular tissue. Biochim Biophys Acta 1993;1203:131-41
34. Lovell MA, Xie C, Markesbery WR. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 1998;51:1562-66
35. Zhao T, Singhal SS, Piper JT, et al. The role of glutathione S-transferases hGSTAI-1 and hGSTA2-2 in protection against oxidative stress. Arch Biochem Biophys 1999;367:216-24
36. Singhal SS, Awasthi S, Srivastava SK, Zimniak P, Ansari NH, Awasthi YC. Novel human ocular glutathione S-transferases with high activity toward 4-hydroxynonenal. Invest Ophthalmol Vis Sci 1995;36:142-50